메뉴 건너뛰기




Volumn 13, Issue 8, 2013, Pages 1195-1219

Acat inhibitors: The search for novel cholesterol lowering agents

Author keywords

Acat inhibitors; Acyl coa: cholesterol o acyl transferase (ACAT); Atherosclerosis; Cholesterol; Cholesterol esterification; Hyperlipidemia

Indexed keywords

1 2 DIARYLETHYLAMINE; 2, 2 DIMETHYL N (2, 4, 6 TRIMETHOXYPHENYL) DODECANAMIDE; 2,2 DIMETHYL N (2,4,6 TRIMETHOXYPHENYL)DODECANAMIDE; 3 (2, 4 DIFLUOROPHENYL) 1 HEPTYL 1 (4 NEOPENTYLBENZYL) UREA; 3 (2,4 DIFLUOROPHENYL) 1 HEPTYL 1 (4 NEOPENTYLBENZYL)UREA; AMINOKETONE; ANILIDE; ATORVASTATIN; AVASIMIBE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CIS [2 (4 HYDROXYPHENYL) 1 INDANYL]DIPHENYLACETAMIDE; CP 113; CP 818; EFLUCIMIBE; FR 179254; FR 182980; FR 186054; KF 17828; LECIMIBIDE; MELINAMIDE; N (2,2 DIMETHYL 2,3 DIHYDROBENZOFURAN 7 YL)AMIDE; PACTIMIBE; PD 129337; PR 109; PR 45; PYRAZOLONE DERIVATIVE; R 755; SM 32504; SMP 797; TEI 6620; TMP 153; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84881522942     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313080007     Document Type: Review
Times cited : (32)

References (141)
  • 3
    • 2342529102 scopus 로고    scopus 로고
    • Lipid lowering activity of drugs affecting cholesterol absorption
    • Norata, G.D.; Catapano, A.L. Lipid lowering activity of drugs affecting cholesterol absorption. Nutr. Metab. Cardiovasc. Dis. 2004, 14, 42-51.
    • (2004) Nutr. Metab. Cardiovasc. Dis , vol.14 , pp. 42-51
    • Norata, G.D.1    Catapano, A.L.2
  • 4
    • 0031715094 scopus 로고    scopus 로고
    • The pathophysiology of atherosclerosis
    • Mitchell, M.E., Sidawy, A.N. The pathophysiology of atherosclerosis. Semin Vasc Surg. 1998, 11, 134-141.
    • (1998) Semin Vasc Surg , vol.11 , pp. 134-141
    • Mitchell, M.E.1    Sidawy, A.N.2
  • 6
    • 0034723758 scopus 로고    scopus 로고
    • The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
    • Pearson, A.T.; Laurora, I.; Chu, H.; Kafonek, S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch. Intern. Med. 2000, 160, 459-467.
    • (2000) Arch. Intern. Med , vol.160 , pp. 459-467
    • Pearson, A.T.1    Laurora, I.2    Chu, H.3    Kafonek, S.4
  • 7
    • 0032032592 scopus 로고    scopus 로고
    • Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia
    • Jones, P.; Kafonek, S.; Laurora, I.; Hunninghake, D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia. Am. J. Cardiol. 1998, 81, 582-587.
    • (1998) Am. J. Cardiol , vol.81 , pp. 582-587
    • Jones, P.1    Kafonek, S.2    Laurora, I.3    Hunninghake, D.4
  • 8
    • 0041706236 scopus 로고    scopus 로고
    • Metabolic effects of plant sterols and stanols
    • Jong, de A.; Plat, J.; Mensink, R.P. Metabolic effects of plant sterols and stanols. J. Nutr. Biochem. 2003, 14, 362-369.
    • (2003) J. Nutr. Biochem , vol.14 , pp. 362-369
    • Jong, D.A.1    Plat, J.2    Mensink, R.P.3
  • 9
    • 0142183214 scopus 로고    scopus 로고
    • Acyl coenzyme A: Cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis
    • Miyazaki, M.; Sakai, Y.; Sakamoto, S.H. Acyl coenzyme A: cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Curr. Opin. Investig. Drugs. 2003, 4, 1095-1099.
    • (2003) Curr. Opin. Investig. Drugs , vol.4 , pp. 1095-1099
    • Miyazaki, M.1    Sakai, Y.2    Sakamoto, S.H.3
  • 10
  • 12
    • 0018616737 scopus 로고
    • Esterification of cholesterol in human small intestine: The importance of Acyl CoA: Cholesterol acyltransferase
    • Norum, K.R.; Lilljeqvist, A.C.; Helgerud, P.; Normann E.R.; Mo, A.; Selbekk, B. Esterification of cholesterol in human small intestine: the importance of Acyl CoA: cholesterol acyltransferase. Eur. J. Clin. Invest. 1979, 9, 55-62.
    • (1979) Eur. J. Clin. Invest , vol.9 , pp. 55-62
    • Norum, K.R.1    Lilljeqvist, A.C.2    Helgerud, P.3    Normann, E.R.4    Mo, A.5    Selbekk, B.6
  • 13
    • 0021043541 scopus 로고
    • Role of Acyl CoA: Cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in rabbit
    • Heider, J.G.; Pickens, C.E.; Kelly, L.A. Role of Acyl CoA: cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in rabbit. J. Lipid. Res. 1983, 24, 1127-1134.
    • (1983) J. Lipid. Res , vol.24 , pp. 1127-1134
    • Heider, J.G.1    Pickens, C.E.2    Kelly, L.A.3
  • 14
    • 0021237202 scopus 로고
    • Intestinal cholesterol esterase: Intracellular enzyme or contamination of cytosol by pancreatic enzymes
    • Field, F.J. Intestinal cholesterol esterase: intracellular enzyme or contamination of cytosol by pancreatic enzymes. J. Lipid. Res., 1984, 25, 389-399.
    • (1984) J. Lipid. Res , vol.25 , pp. 389-399
    • Field, F.J.1
  • 15
    • 0022256566 scopus 로고
    • Role of acyl Co-A: Cholesterol acyl transferase in cellular cholesterol metabolism
    • Suckling, K.E.; Stange, E F. Role of acyl Co-A: cholesterol acyl transferase in cellular cholesterol metabolism. J. Lipid Res. 1985, 26, 647-671.
    • (1985) J. Lipid Res , vol.26 , pp. 647-671
    • Suckling, K.E.1    Stange, E.F.2
  • 16
    • 0019430455 scopus 로고
    • Acyl-CoA: Cholesterol acyltransferase in human small intestine: Its activity and some properties of enzymic action
    • Helgerud, P.; Saarem, K.; Nonm, K.R. Acyl-CoA: cholesterol acyltransferase in human small intestine: its activity and some properties of enzymic action. J. Lipid. Res. 1981, 22, 271-277.
    • (1981) J. Lipid. Res , vol.22 , pp. 271-277
    • Helgerud, P.1    Saarem, K.2    Nonm, K.R.3
  • 17
    • 84892439816 scopus 로고    scopus 로고
    • Health.allrefer.com/pictures-images/enlarged-view-ofatherosclerosis.html.
  • 18
    • 63349109364 scopus 로고    scopus 로고
    • Acyl coenzymeA: Cholesterol acyltransferase family
    • Liu, Y.; Guo, Z. Acyl coenzymeA: cholesterol acyltransferase family. Front. Biol. China. 2009, 4, 129-136.
    • (2009) Front. Biol. China , vol.4 , pp. 129-136
    • Liu, Y.1    Guo, Z.2
  • 19
    • 51449089950 scopus 로고    scopus 로고
    • Identification of putative active site residues of ACAT enzymes
    • Das, A.; Davis, M.A.; Rudel, L.L. Identification of putative active site residues of ACAT enzymes. J. Lipid. Res. 2008. 49, 1770-1781.
    • (2008) J. Lipid. Res , vol.49 , pp. 1770-1781
    • Das, A.1    Davis, M.A.2    Rudel, L.L.3
  • 20
    • 0034672691 scopus 로고    scopus 로고
    • Mammalian Acyl CoA: Cholesterol acyltransferases
    • Buhman, K.F.; Accad, M.; Farese, R.V. Mammalian Acyl CoA: cholesterol acyltransferases. 2000. Biochim. Biophys. Acta. 1529. 142-154.
    • (2000) Biochim. Biophys. Acta , vol.1529 , pp. 142-154
    • Buhman, K.F.1    Accad, M.2    Farese, R.V.3
  • 21
    • 0025756150 scopus 로고
    • Therapeutic potential of ACAT inhibitors as lipid lowering and antiatherosclerotic agents
    • Sliskovic, D.R.; White, A.D. Therapeutic potential of ACAT inhibitors as lipid lowering and antiatherosclerotic agents. Trends. Pharmacol. Sci. 1991, 12, 194-199.
    • (1991) Trends. Pharmacol. Sci , vol.12 , pp. 194-199
    • Sliskovic, D.R.1    White, A.D.2
  • 22
    • 0023882098 scopus 로고
    • Isolation and characterization of Chinese hamster ovary cell mutants deficient an acyl-coenzyme A: Cholesterol acyltransferase activity
    • Cadigan, K.M.; Heider, J.G.; Chang, T.Y. Isolation and characterization of Chinese hamster ovary cell mutants deficient an acyl-coenzyme A: cholesterol acyltransferase activity. J. Biol. Chem., 1988, 263, 274-282.
    • (1988) J. Biol. Chem , vol.263 , pp. 274-282
    • Cadigan, K.M.1    Heider, J.G.2    Chang, T.Y.3
  • 23
    • 0027527733 scopus 로고
    • Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells
    • Chang, C.C.; Huh, H.Y.; Cadigan, K.M., Chang, T.Y. Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 1993, 268, 20747-20755.
    • (1993) J. Biol. Chem , vol.268 , pp. 20747-20755
    • Chang, C.C.1    Huh, H.Y.2    Cadigan, K.M.3    Chang, T.Y.4
  • 31
    • 3342943329 scopus 로고    scopus 로고
    • ACAT inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1 and low-density lipoprotein receptor deficiencies in nephritic syndrome
    • Vaziri, N.D.; Liang, K.H. ACAT inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1 and low-density lipoprotein receptor deficiencies in nephritic syndrome. Circulation. 2004, 110, 419-425.
    • (2004) Circulation , vol.110 , pp. 419-425
    • Vaziri, N.D.1    Liang, K.H.2
  • 32
    • 0033551669 scopus 로고    scopus 로고
    • Human ACAT-1 in the endoplasmic reticulum contains seven transmembrane domains
    • Lin, S.; Cheng, D.; Liu, M.S.; Chen, J.; Cheng, T.Y. Human ACAT-1 in the endoplasmic reticulum contains seven transmembrane domains. J. Biol. Chem., 1999, 274, 23276-23285.
    • (1999) J. Biol. Chem , vol.274 , pp. 23276-23285
    • Lin, S.1    Cheng, D.2    Liu, M.S.3    Chen, J.4    Cheng, T.Y.5
  • 33
    • 0033739779 scopus 로고    scopus 로고
    • ACAT-1 and ACAT-2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane
    • Joyce, C.W.; Shelness, G.S.; Davis, M.A.; Lee, R.G.; Skinner, K.; Anderson, R.A.; Rudel, L.L. ACAT-1 and ACAT-2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol. Biol. Cell. 2000, 11, 3675-3687.
    • (2000) Mol. Biol. Cell , vol.11 , pp. 3675-3687
    • Joyce, C.W.1    Shelness, G.S.2    Davis, M.A.3    Lee, R.G.4    Skinner, K.5    Anderson, R.A.6    Rudel, L.L.7
  • 34
    • 27844475676 scopus 로고    scopus 로고
    • The active site His-460 of human Acyl-coenzyme A: Cholesterol acyltransferase 1 residues in a hitherto undisclosed tranmembrane domain
    • Guo, Z.Y.; Lin, S.; Heinen, J.A.; Chang, C.C.; Chang, T. The active site His-460 of human Acyl-coenzyme A: cholesterol acyltransferase 1 residues in a hitherto undisclosed tranmembrane domain. J. Biol. Chem. 2005, 280, 37814-37826.
    • (2005) J. Biol. Chem , vol.280 , pp. 37814-37826
    • Guo, Z.Y.1    Lin, S.2    Heinen, J.A.3    Chang, C.C.4    Chang, T.5
  • 35
    • 0037632868 scopus 로고    scopus 로고
    • Human acyl-coenzyme A: Cholesterase expressed in Chinese hamster ovary cells: Membrane topology and active site location Mol
    • Lin, S.; Lu, X.; Chang, C.C.; Chang, T.Y. Human acyl-coenzyme A: cholesterase expressed in Chinese hamster ovary cells: membrane topology and active site location Mol. Biol. Cell., 2003, 14, 2447-2460.
    • (2003) Biol. Cell , vol.14 , pp. 2447-2460
    • Lin, S.1    Lu, X.2    Chang, C.C.3    Chang, T.Y.4
  • 36
    • 0025756150 scopus 로고
    • Therapeutic potential of ACAT inhibitors as lipid lowring and antiatherosclerotic agents
    • Sliskovic, D.R.; White, A.D. Therapeutic potential of ACAT inhibitors as lipid lowring and antiatherosclerotic agents. Trends in Pharmacol. Sci., 1991, 12, 194-199.
    • (1991) Trends In Pharmacol. Sci , vol.12 , pp. 194-199
    • Sliskovic, D.R.1    White, A.D.2
  • 37
    • 0034520194 scopus 로고    scopus 로고
    • Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, Kidney and adrenal of nonhuman primates
    • Lee, R.G.; Willingham, M.C.; Davis, M.A.; Skinner, K.A.; Rudel, L.L. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, Kidney and adrenal of nonhuman primates. J. Lipid. Res. 2000. 41. 1991-2001.
    • (2000) J. Lipid. Res , vol.41 , pp. 1991-2001
    • Lee, R.G.1    Willingham, M.C.2    Davis, M.A.3    Skinner, K.A.4    Rudel, L.L.5
  • 38
    • 0011452376 scopus 로고
    • Factors facilitating cholesterol absorption from the intestine via lymphatic pathways
    • Vahouny, G.; Falwal, V.; Treadwell, C.R. Factors facilitating cholesterol absorption from the intestine via lymphatic pathways. Am. J. Physiol. 1957, 188, 342-346.
    • (1957) Am. J. Physiol , vol.188 , pp. 342-346
    • Vahouny, G.1    Falwal, V.2    Treadwell, C.R.3
  • 39
    • 0023154980 scopus 로고
    • Normal cholesterol absorption in rats deficient in intestinal ACAT activity
    • Gallo, L.L.; Wadsworth, J.A.; Vahouny, G.V. Normal cholesterol absorption in rats deficient in intestinal ACAT activity. J. Lipid Res. 1987, 28, 381.
    • (1987) J. Lipid Res , vol.28 , pp. 381
    • Gallo, L.L.1    Wadsworth, J.A.2    Vahouny, G.V.3
  • 40
    • 0024389312 scopus 로고
    • CL 277,082: A novel inhibitor of ACAT-catalysed cholesterol esterificationand cholesterol absorption
    • Largis, E.F.; Wang, C.H.; Davries, V.G.; Schaffer, S.A. CL 277,082: A novel inhibitor of ACAT-catalysed cholesterol esterificationand cholesterol absorption. J. Lipid. Res. 1989, 30, 681-690.
    • (1989) J. Lipid. Res , vol.30 , pp. 681-690
    • Largis, E.F.1    Wang, C.H.2    Davries, V.G.3    Schaffer, S.A.4
  • 41
    • 0017670576 scopus 로고
    • Studies of the mechanism of augmented synthesis of cholesterol ester in atherosclerotic rabbit aortic microsomes
    • Hashimoto, S.; Dayton, S. Studies of the mechanism of augmented synthesis of cholesterol ester in atherosclerotic rabbit aortic microsomes. Athrosclerosis. 1977, 28, 447-452.
    • (1977) Athrosclerosis , vol.28 , pp. 447-452
    • Hashimoto, S.1    Dayton, S.2
  • 43
    • 0025667289 scopus 로고
    • Regulation of apo B secretion from HepG2 cells: Evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge
    • Cianflone, K M.; Yasruel, Z.; Rodriguez, M.A.; Sniderman, A.D. Regulation of apo B secretion from HepG2 cells: Evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 1990, 31, 2045-2055.
    • (1990) J. Lipid Res , vol.31 , pp. 2045-2055
    • Cianflone, K.M.1    Yasruel, Z.2    Rodriguez, M.A.3    Sniderman, A.D.4
  • 44
    • 0027405261 scopus 로고
    • Enzymatic determination of triglyceride, free cholesterol and total cholesterol in tissue extracts
    • Carr, T.P.; Rudell, L.L. Enzymatic determination of triglyceride, free cholesterol and total cholesterol in tissue extracts. Clin. Biochem. 1993, 26. 39-42.
    • (1993) Clin. Biochem , vol.26 , pp. 39-42
    • Carr, T.P.1    Rudell, L.L.2
  • 45
    • 0023225958 scopus 로고
    • Inhibition of total cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblast
    • Middleton, B. Inhibition of total cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblast. Biochem. Biophys. Res. Commun. 1987, 145, 350-356.
    • (1987) Biochem. Biophys. Res. Commun , vol.145 , pp. 350-356
    • Middleton, B.1
  • 46
    • 0021320894 scopus 로고
    • Selective inhibition of ACAT by compound 58-035
    • Ross, A.C.; Go, K.J.; Heider, J.G. Selective inhibition of ACAT by compound 58-035. J. Biol. Chem. 1984, 259, 815-819.
    • (1984) J. Biol. Chem , vol.259 , pp. 815-819
    • Ross, A.C.1    Go, K.J.2    Heider, J.G.3
  • 47
    • 0022518433 scopus 로고
    • Hepatic ACAT. Development of a standard assay and determination in patients with cholesterol gallstones
    • Smith, J.L.; DeJersey, J.; Pillay, S.P.; Hardie, J.R. Hepatic ACAT. Development of a standard assay and determination in patients with cholesterol gallstones. Clin. Chim. Acta. 1986, 158, 271-282.
    • (1986) Clin. Chim. Acta , vol.158 , pp. 271-282
    • Smith, J.L.1    Dejersey, J.2    Pillay, S.P.3    Hardie, J.R.4
  • 48
    • 0020972414 scopus 로고
    • Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
    • Brown, M.S.; Goldstein, J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Res. Biochem. 1983, 52, 223-261.
    • (1983) Annu. Res. Biochem , vol.52 , pp. 223-261
    • Brown, M.S.1    Goldstein, J.L.2
  • 49
    • 0024603895 scopus 로고
    • Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogeniciy
    • Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J.C.; Witzum, J.L. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogeniciy. New Engl. J. Med. 1989, 320, 915-924.
    • (1989) New Engl. J. Med , vol.320 , pp. 915-924
    • Steinberg, D.1    Parthasarathy, S.2    Carew, T.E.3    Khoo, J.C.4    Witzum, J.L.5
  • 50
    • 0027527733 scopus 로고
    • Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells
    • Chang, C.C.; Huh, H.Y.; Cadigan, K.M.; Chang, T.Y. Molecular cloning and functional expression of human ACAT cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 1993, 268, 20747-20755.
    • (1993) Biol. Chem , vol.268 , pp. 20747-20755
    • Chang, C.C.1    Huh, H.Y.2    Cadigan, K.M.3    Chang, T.Y.4
  • 51
    • 20144365248 scopus 로고    scopus 로고
    • ACAT2 is a target for treatment of coronary heart disease associated hypercholesterolemia
    • Rudel, L.L.; Lee, R.G.; Parini, P. ACAT2 is a target for treatment of coronary heart disease associated hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2005. 25. 1112-1118.
    • (2005) Arterioscler. Thromb. Vasc. Biol , vol.25 , pp. 1112-1118
    • Rudel, L.L.1    Lee, R.G.2    Parini, P.3
  • 53
    • 0023028820 scopus 로고
    • Mechanism of the inhibition of cholesterol absorption by DLmelinamide: Inhibition of cholesterol esterification. Jpn
    • Natori, K.; Okazaki, Y.; Nakajima, T.; Hirohashi, T.; Aono, S. Mechanism of the inhibition of cholesterol absorption by DLmelinamide: inhibition of cholesterol esterification. Jpn. J. Pharmacol. 1986, 42, 517-523.
    • (1986) J. Pharmacol , vol.42 , pp. 517-523
    • Natori, K.1    Okazaki, Y.2    Nakajima, T.3    Hirohashi, T.4    Aono, S.5
  • 54
    • 0026668238 scopus 로고
    • Inhibitor of Acyl-CoA:Cholesterol Acyltransferase. Identification and Structure-Activity Relationships of a novel series of fatty acid anilide hypocholesterolemic agents
    • Roth, B.D.; Blankley, C.J.; Hoefle, M.L.; Holme, A.; Roark, H.; Trivedi, B.K.; Essenburg, A. D.; Kieft, K.A.; Krause, B.R.; Stanfield, R.L. Inhibitor of Acyl-CoA:Cholesterol Acyltransferase. Identification and Structure-Activity Relationships of a novel series of fatty acid anilide hypocholesterolemic agents. J. Med. Chem. 1992, 35, 1609-1617.
    • (1992) J. Med. Chem , vol.35 , pp. 1609-1617
    • Roth, B.D.1    Blankley, C.J.2    Hoefle, M.L.3    Holme, A.4    Roark, H.5    Trivedi, B.K.6    Essenburg, A.D.7    Kieft, K.A.8    Krause, B.R.9    Stanfield, R.L.10
  • 55
    • 0026347265 scopus 로고
    • Comparision of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological and morphometric evaluation
    • Bocan, T.M.A.; Bak Muller, S.; Uhlehndorf, P.D.; Newton, R.S.; Krause, B.R. Comparision of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological and morphometric evaluation. Arteri. Throm. 1991, 11, 1830-1843.
    • (1991) Arteri. Throm , vol.11 , pp. 1830-1843
    • Bocan, T.M.A.1    Bak, M.S.2    Uhlehndorf, P.D.3    Newton, R.S.4    Krause, B.R.5
  • 57
    • 0028889942 scopus 로고
    • ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys
    • Carr, T.P.; Hamilton, R.L. jr.; Rudel, L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. Lipid Research, 1995, 36, 25-36.
    • (1995) Lipid Research , vol.36 , pp. 25-36
    • Carr, T.P.1    Hamilton Jr., R.L.2    Rudel, L.L.3
  • 60
    • 0002624168 scopus 로고
    • ACAT inhibitors: Potential antiatherosclerotic agents
    • Sliscovic D.R.; Trivedi, B.K. ACAT inhibitors: potential antiatherosclerotic agents. Curr. Med. Chem. 1994, 1, 204-224.
    • (1994) Curr. Med. Chem , vol.1 , pp. 204-224
    • Sliscovic, D.R.1    Trivedi, B.K.2
  • 62
    • 0028819250 scopus 로고
    • ACAT as hypocholesterolemic agents. 12. Synthesis and biological activity of structurally novel tetrazole amide
    • ACAT as hypocholesterolemic agents. 12. Synthesis and biological activity of structurally novel tetrazole amide. Bioorg. Med. Chem. Lett. 1995, 5, 289-294.
    • (1995) Bioorg. Med. Chem. Lett , vol.5 , pp. 289-294
  • 63
    • 0028855474 scopus 로고
    • Inhibitors of ACAT as hypocholesterolemic agents. 13. Design, synthesis and biological evaluation of tetrazole anilides as potent inhibitors of ACAT in vitro and hypocholesterolemic agents in vivo
    • O'Brien, P.M.; Sliskovic, D.R.; Anderson, M.K.; Bousley, R.F.; Krause, B.R.; Stanfield, R.L. Inhibitors of ACAT as hypocholesterolemic agents. 13. Design, synthesis and biological evaluation of tetrazole anilides as potent inhibitors of ACAT in vitro and hypocholesterolemic agents in vivo. Bioorg. Med. Chem. Lett. 1995, 5, 295-300.
    • (1995) Bioorg. Med. Chem. Lett , vol.5 , pp. 295-300
    • O'Brien, P.M.1    Sliskovic, D.R.2    Anderson, M.K.3    Bousley, R.F.4    Krause, B.R.5    Stanfield, R.L.6
  • 64
    • 0029898322 scopus 로고    scopus 로고
    • Inhibitors of ACAT. Synthesis and pharmacological activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6- trimethoxyphenyl)-2H-tetrazole-5-acetamide and structurally related tetrazole amide derivatives
    • O'Brien, P.M.; Sliskovic, D.R.; Picard, J.A.; Lee, H.T.; Purchase, C.F.; Roth, B.D.; White, A.D. Inhibitors of ACAT. Synthesis and pharmacological activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6- trimethoxyphenyl)-2H-tetrazole-5-acetamide and structurally related tetrazole amide derivatives. J. Med. Chem. 1996, 39, 2354-2366.
    • (1996) J. Med. Chem , vol.39 , pp. 2354-2366
    • O'Brien, P.M.1    Sliskovic, D.R.2    Picard, J.A.3    Lee, H.T.4    Purchase, C.F.5    Roth, B.D.6    White, A.D.7
  • 65
    • 10144229124 scopus 로고    scopus 로고
    • Heterocyclic amides: Inhibitors of ACAT with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit
    • White, A.D.; Purchase, C.F.; Picard, J.A.; Anderson, M.K.; Mueller, S.K. Heterocyclic amides: inhibitors of ACAT with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit. J. Med. Chem. 1996, 39, 3908-3919.
    • (1996) J. Med. Chem , vol.39 , pp. 3908-3919
    • White, A.D.1    Purchase, C.F.2    Picard, J.A.3    Anderson, M.K.4    Mueller, S.K.5
  • 66
    • 0028214973 scopus 로고
    • Inhibitors of ACAT. Synthesis and hypocholesterolemic activity of Dibenz[b,e]oxepin-11-carboxamides
    • Kumazaya, T.; Yanase, M.; Harakawa, H.; Obase, H.; Shirakura, S. Inhibitors of ACAT. Synthesis and hypocholesterolemic activity of Dibenz[b,e]oxepin-11-carboxamides. J. Med. Chem. 1994, 37, 804-810.
    • (1994) J. Med. Chem , vol.37 , pp. 804-810
    • Kumazaya, T.1    Yanase, M.2    Harakawa, H.3    Obase, H.4    Shirakura, S.5
  • 67
    • 0029143099 scopus 로고
    • Amides of piperidine, morpholine and piperazine substituted 1- phenylethylamines: Inhibitors of ACAT activity in vitro and in vivo
    • Dugar, S.; Davis, H.R.; Burrier, R.E.; Salisbury, B.G. Amides of piperidine, morpholine and piperazine substituted 1- phenylethylamines: inhibitors of ACAT activity in vitro and in vivo. Bioorg. Med. Chem. 1995, 3, 1231-1236.
    • (1995) Bioorg. Med. Chem , vol.3 , pp. 1231-1236
    • Dugar, S.1    Davis, H.R.2    Burrier, R.E.3    Salisbury, B.G.4
  • 69
    • 0029875106 scopus 로고    scopus 로고
    • Potent inhibitors of ACAT: SARs of novel N-(2,2-Dimethyl-2,3- dihydrobenzofuran-7-yl)amides
    • Kataoka, K.; Shiota, T.; Takeyasu, T.; Mochizuki, T.; Taneda, K. Potent inhibitors of ACAT: SARs of novel N-(2,2-Dimethyl-2,3- dihydrobenzofuran-7-yl)amides. J. Med. Chem. 1996, 39, 1262-1270.
    • (1996) J. Med. Chem , vol.39 , pp. 1262-1270
    • Kataoka, K.1    Shiota, T.2    Takeyasu, T.3    Mochizuki, T.4    Taneda, K.5
  • 70
    • 0034935946 scopus 로고    scopus 로고
    • SARs of N-(3,5- Dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl) piperazine and analogs as inhibitors of ACAT
    • Ohishi, K.; Aiama, R.; Hatano, H.; Yoshida, Y.; Wada, Y.; Wakae, Y.; Sawada, H.; Watanabe, T.; Yokokura, T. SARs of N-(3,5- Dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl) piperazine and analogs as inhibitors of ACAT. Chem. Pharm. Bull. 2001, 49, 830-839.
    • (2001) Chem. Pharm. Bull , vol.49 , pp. 830-839
    • Ohishi, K.1    Aiama, R.2    Hatano, H.3    Yoshida, Y.4    Wada, Y.5    Wakae, Y.6    Sawada, H.7    Watanabe, T.8    Yokokura, T.9
  • 72
    • 0036985469 scopus 로고    scopus 로고
    • ACAT inhibitors: The search for a novel and effective treatment of hypocholesterolemia and atherosclerosis
    • Sliskovic, D.R.; Picard, J.A.; Krause, B.R. ACAT inhibitors: The search for a novel and effective treatment of hypocholesterolemia and atherosclerosis. Prog. In Med. Chem. 2002, 39, 121-171.
    • (2002) Prog. In Med. Chem , vol.39 , pp. 121-171
    • Sliskovic, D.R.1    Picard, J.A.2    Krause, B.R.3
  • 73
    • 0020518669 scopus 로고
    • Potential anti-atherosclerotic agents. 4.[(Functionalizedalkyl)amino]benzoic acid analogs of cetaben
    • De Vries, V.G.; Largis, E.E.; Miner, T.G.; Shepherd, R.G.; Upeslachis, J. Potential anti-atherosclerotic agents. 4.[(Functionalizedalkyl)amino]benzoic acid analogs of cetaben. J. Med. Chem. 1983, 26, 1411-1421.
    • (1983) J. Med. Chem , vol.26 , pp. 1411-1421
    • de Vries, V.G.1    Largis, E.E.2    Miner, T.G.3    Shepherd, R.G.4    Upeslachis, J.5
  • 75
    • 0028821570 scopus 로고
    • ACAT inhibitors: Ureas bearing two heterocyclic head groups
    • Wilde, R.G.; Billheimer, J.T. ACAT inhibitors: Ureas bearing two heterocyclic head groups. Bioorg. & Med. Chem. Lett. 1995, 5, 173-176.
    • (1995) Bioorg. & Med. Chem. Lett , vol.5 , pp. 173-176
    • Wilde, R.G.1    Billheimer, J.T.2
  • 82
    • 0035033577 scopus 로고    scopus 로고
    • Novel hydroxyhenylurea dual inhibitor against ACAT and low density lipoprotein (LDL)oxidation as antiatherosclerotic agent
    • Nakao, K.; Kubota, H.; Yasuhara, M.; Saito, K.; Suzuki, T.; Ohmizu, H.; Shimizu, R. Novel hydroxyhenylurea dual inhibitor against ACAT and low density lipoprotein (LDL)oxidation as antiatherosclerotic agent. Bioorg. & Med. Chem. 2001, 9, 853-861.
    • (2001) Bioorg. & Med. Chem , vol.9 , pp. 853-861
    • Nakao, K.1    Kubota, H.2    Yasuhara, M.3    Saito, K.4    Suzuki, T.5    Ohmizu, H.6    Shimizu, R.7
  • 84
    • 28144457982 scopus 로고    scopus 로고
    • Mono- or Diphenylpyridazines connected to N-(2,4-Diflurophenyl)-N'-heptylureas as ACAT inhibitors
    • Gelain, A.; Bettinelli, I.; Barlocco, D.; Kwon, B.W.; Jeong, T. S.; Cho, K.H.; Toma, L. Mono- or Diphenylpyridazines connected to N-(2,4-Diflurophenyl)-N'-heptylureas as ACAT inhibitors. J. Med. Chem. 2005, 48, 7708-7713.
    • (2005) J. Med. Chem , vol.48 , pp. 7708-7713
    • Gelain, A.1    Bettinelli, I.2    Barlocco, D.3    Kwon, B.W.4    Jeong, T.S.5    Cho, K.H.6    Toma, L.7
  • 86
    • 0027156260 scopus 로고
    • SAR of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of ACAT with Anti-atherosclerotic activity
    • Kimura, T.; Watanabe, N.; Matsui, M.; Hayashi, K.; Tanaka, H.; Ohtsuka, I.; Saeki, T.; Yamatsu, I. SAR of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of ACAT with Anti-atherosclerotic activity. J. Med. Chem. 1993, 36, 1641-1653.
    • (1993) J. Med. Chem , vol.36 , pp. 1641-1653
    • Kimura, T.1    Watanabe, N.2    Matsui, M.3    Hayashi, K.4    Tanaka, H.5    Ohtsuka, I.6    Saeki, T.7    Yamatsu, I.8
  • 88
    • 0028236806 scopus 로고
    • Inhibitors of ACAT. 7. Development of a series of substituted Nphenyl- N'-[(1-phenylcyclopentl)methyl]ureas with enhanced hypocholesterolemic activity
    • Trivedi, B.K.; Purchase, T.S.; Holmes, A.; Augelli-Szafran, C.E.; Hamelehle, K.L.; Stanfield, R.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT. 7. Development of a series of substituted Nphenyl- N'-[(1-phenylcyclopentl)methyl]ureas with enhanced hypocholesterolemic activity. J. Med. Chem. 1994, 37, 1652-1659.
    • (1994) J. Med. Chem , vol.37 , pp. 1652-1659
    • Trivedi, B.K.1    Purchase, T.S.2    Holmes, A.3    Augelli-Szafran, C.E.4    Hamelehle, K.L.5    Stanfield, R.L.6    Bousley, R.F.7    Krause, B.R.8
  • 90
    • 0027283726 scopus 로고
    • Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD-132301-2, an inhibitor of ACAT
    • Dominick, M.A.; Bobrowski, W.F.; Mac Donald, J.R.; Gough, A.W. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD-132301-2, an inhibitor of ACAT. Toxicol. Pathol. 1993, 21, 54-62.
    • (1993) Toxicol. Pathol , vol.21 , pp. 54-62
    • Dominick, M.A.1    Bobrowski, W.F.2    Donald, J.R.3    Gough, A.W.4
  • 92
    • 0028286581 scopus 로고
    • Inhibitors of ACAT as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo
    • O'Brien, P.M.; Silskovic, D.R.; Blankley, C.J.; Roth, B.D.; Wilson, M.W.; Hamelehle, K. L.; Krause, B.R.; Stanfield, R.L. Inhibitors of ACAT as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo. J. Med. Chem. 1994, 37, 1810-1822.
    • (1994) J. Med. Chem , vol.37 , pp. 1810-1822
    • O'Brien, P.M.1    Silskovic, D.R.2    Blankley, C.J.3    Roth, B.D.4    Wilson, M.W.5    Hamelehle, K.L.6    Krause, B.R.7    Stanfield, R.L.8
  • 95
    • 0035004680 scopus 로고    scopus 로고
    • Pharmacolocgical properties of R-755, a novel ACAT inhibitor, in Cholesterol-fed rats, hamsters and rabbits
    • Matsui, Y.; Horiuchi, K.; Yamamoto, K.; Kanai, K. Pharmacolocgical properties of R-755, a novel ACAT inhibitor, in Cholesterol-fed rats, hamsters and rabbits. Jpn. J. Pharmacol. 2001, 85, 423-433.
    • (2001) Jpn. J. Pharmacol , vol.85 , pp. 423-433
    • Matsui, Y.1    Horiuchi, K.2    Yamamoto, K.3    Kanai, K.4
  • 98
    • 1242293871 scopus 로고    scopus 로고
    • Synthesis and structure-activity relationship studies on a novel series of naphthylidonoylureas as inhibitors of ACAT
    • Ohnuma, S.; Muraoka, M.; Ioriya, K.; Ohashi, N. Synthesis and structure-activity relationship studies on a novel series of naphthylidonoylureas as inhibitors of ACAT. Bioorg. & Med. Chem. Lett. 2004, 14, 1309-1311.
    • (2004) Bioorg. & Med. Chem. Lett , vol.14 , pp. 1309-1311
    • Ohnuma, S.1    Muraoka, M.2    Ioriya, K.3    Ohashi, N.4
  • 99
    • 24944561845 scopus 로고    scopus 로고
    • Synthesis of SMP-797: A new potent ACAT inhibitor
    • Ban, H.; Muraoka, M.; Ohashi, N. Synthesis of SMP-797: a new potent ACAT inhibitor. Tetrahedron. 2005, 61, 10081-10092.
    • (2005) Tetrahedron , vol.61 , pp. 10081-10092
    • Ban, H.1    Muraoka, M.2    Ohashi, N.3
  • 100
    • 59649104957 scopus 로고    scopus 로고
    • Novel 1,4- diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: Dual effectors on ACAT and low-density lipoprotein receptor expression
    • Asano, S.; Ban, H.; Kino, K.; Ioriya, K.; Maraoka, M. Novel 1,4- diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on ACAT and low-density lipoprotein receptor expression. Bioorg. & Med. Chem. Lett. 2009, 19, 1062-1065.
    • (2009) Bioorg. & Med. Chem. Lett , vol.19 , pp. 1062-1065
    • Asano, S.1    Ban, H.2    Kino, K.3    Ioriya, K.4    Maraoka, M.5
  • 101
    • 66449122310 scopus 로고    scopus 로고
    • Synthesis and SARs of N-(4-amino-2,6-diisopropyl-phenyl)-N'- (1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents
    • Asano, S.; Ban, H.; Kino, K.; Ioriya, K.; Maraoka, M. Synthesis and SARs of N-(4-amino-2,6-diisopropyl-phenyl)-N'- (1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents. Bioorg. & Med. Chem. 2009, 17, 4636-4646.
    • (2009) Bioorg. & Med. Chem , vol.17 , pp. 4636-4646
    • Asano, S.1    Ban, H.2    Kino, K.3    Ioriya, K.4    Maraoka, M.5
  • 105
    • 0028819251 scopus 로고
    • Inhibitors of ACAT as hypocholesterolemic agents. 14. Synthesis and SARs of a novel series of sulphonamide tetrazoles
    • Lee, H.T.; Sliskovic, D.R.; Stanfield, R.L.; Hamlehle, K.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT as hypocholesterolemic agents. 14. Synthesis and SARs of a novel series of sulphonamide tetrazoles. Bioorg. & Med. Chem. Lett. 1995, 5, 301-306.
    • (1995) Bioorg. & Med. Chem. Lett , vol.5 , pp. 301-306
    • Lee, H.T.1    Sliskovic, D.R.2    Stanfield, R.L.3    Hamlehle, K.L.4    Bousley, R.F.5    Krause, B.R.6
  • 107
    • 0030472785 scopus 로고    scopus 로고
    • Inhibitors of ACAT as hypocholesterolemic agents. CI-1011: An acyl sulfamate with unique Cholesterol-lowering activity in aminals fed noncholesterolsupplemented diets
    • Lee, H.T.; Sliskovic, D. R.; Stanfield, R. L.; Hamlehle, K. L.; Bousley, R. F.; Krause, B. R. Inhibitors of ACAT as hypocholesterolemic agents. CI-1011: An acyl sulfamate with unique Cholesterol-lowering activity in aminals fed noncholesterolsupplemented diets. J. Med. Chem. 1996, 39, 5031-5034.
    • (1996) J. Med. Chem , vol.39 , pp. 5031-5034
    • Lee, H.T.1    Sliskovic, D.R.2    Stanfield, R.L.3    Hamlehle, K.L.4    Bousley, R.F.5    Krause, B.R.6
  • 108
    • 0032477856 scopus 로고    scopus 로고
    • Inhibitors of ACAT as hypocholesterolemic agents: Synthesis and SARs of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates
    • Lee, H.T.; Roark, W.H.; Sliskovic, D.R.; Stanfield, R.L.; Hamlehle, K.L.; Bousley, R.F.; Krause, B.R. Inhibitors of ACAT as hypocholesterolemic agents: Synthesis and SARs of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates. Bioorg. & Med. Chem. Lett. 1998, 8, 289-294.
    • (1998) Bioorg. & Med. Chem. Lett , vol.8 , pp. 289-294
    • Lee, H.T.1    Roark, W.H.2    Sliskovic, D.R.3    Stanfield, R.L.4    Hamlehle, K.L.5    Bousley, R.F.6    Krause, B.R.7
  • 109
    • 49449088714 scopus 로고    scopus 로고
    • Novel indoline-based ACAT inhibitor with anitperoxidative activity: Improvement of physicochemical properties and biological activities by introduction of carboxylic acid
    • Takahashi, K.; Shoji, Y.; Ohta, M.; Kasai, M.; Kunishiro, K.; Kanda, M.; Yogai, S.; Takeuchi, Y.; Shirahase, H. Novel indoline-based ACAT inhibitor with anitperoxidative activity: Improvement of physicochemical properties and biological activities by introduction of carboxylic acid. J. Med. Chem. 2008, 51, 4823-4833.
    • (2008) J. Med. Chem , vol.51 , pp. 4823-4833
    • Takahashi, K.1    Shoji, Y.2    Ohta, M.3    Kasai, M.4    Kunishiro, K.5    Kanda, M.6    Yogai, S.7    Takeuchi, Y.8    Shirahase, H.9
  • 110
    • 68149110226 scopus 로고    scopus 로고
    • Novel indoline based ACAT inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities
    • Shoji, Y.; Takahashi, K.; Ohta, M.; Kasai, M.; Kunishiro, K.; Kanda, M.; Yogai, S.; Takeuchi, Y.; Shirahase, H. Novel indoline based ACAT inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities. Bioorg. Med. Chem. 2009, 17, 6020-6031.
    • (2009) Bioorg. Med. Chem , vol.17 , pp. 6020-6031
    • Shoji, Y.1    Takahashi, K.2    Ohta, M.3    Kasai, M.4    Kunishiro, K.5    Kanda, M.6    Yogai, S.7    Takeuchi, Y.8    Shirahase, H.9
  • 111
    • 77951133543 scopus 로고    scopus 로고
    • A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia
    • Asano, S.; Ban, H.; Tsuboya, N.; Uno, S.; Kino, K.; Ioriya, K.; Kitano, M.; Ueno, Y. A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia. J. Med. Chem. 2010, 53, 3284-3295.
    • (2010) J. Med. Chem , vol.53 , pp. 3284-3295
    • Asano, S.1    Ban, H.2    Tsuboya, N.3    Uno, S.4    Kino, K.5    Ioriya, K.6    Kitano, M.7    Ueno, Y.8
  • 113
    • 0030593666 scopus 로고    scopus 로고
    • Singlet oxygen oxidation of pyrroles: Synthesis and chemical transformation of novel 4,4-bis(trifluoromethyl)imidazoline analogs
    • Li, H.; Drummond, S.; DeLucca, I.; Boswell, G.A. Singlet oxygen oxidation of pyrroles: Synthesis and chemical transformation of novel 4,4-bis(trifluoromethyl)imidazoline analogs. Tetrahedron. 1996, 52, 11153-11162.
    • (1996) Tetrahedron , vol.52 , pp. 11153-11162
    • Li, H.1    Drummond, S.2    Delucca, I.3    Boswell, G.A.4
  • 114
    • 0030935545 scopus 로고    scopus 로고
    • Asymmetric synthesis and absolute stereochemistry of 4,4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors
    • Li, H.; Drummond, S.; DeLucca, I.; Boswell, G.A. Asymmetric synthesis and absolute stereochemistry of 4,4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors. Tetrahedron. 1997, 53, 5359-5372.
    • (1997) Tetrahedron , vol.53 , pp. 5359-5372
    • Li, H.1    Drummond, S.2    Delucca, I.3    Boswell, G.A.4
  • 115
    • 0026474969 scopus 로고
    • New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305
    • Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305. J. Antibiot. 1992, 45, 1207-1215.
    • (1992) J. Antibiot , vol.45 , pp. 1207-1215
    • Tomoda, H.1    Nishida, H.2    Masuma, R.3    Cao, J.4    Okuda, S.5    Omura, S.6
  • 116
    • 0026498516 scopus 로고
    • Inhibition of ACAT activity by cyclodepsipeptide antibiotics
    • Tomoda, H.; Huang, X.H.; Cao, J. Inhibition of ACAT activity by cyclodepsipeptide antibiotics. J. Antibiot. 1992, 45, 1626-1632.
    • (1992) J. Antibiot , vol.45 , pp. 1626-1632
    • Tomoda, H.1    Huang, X.H.2    Cao, J.3
  • 117
    • 0026030197 scopus 로고
    • Purpactins, a new inhibitors of ACAT produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties
    • Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. Purpactins, a new inhibitors of ACAT produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties. J. Antibiot. 1991, 44, 136-143.
    • (1991) J. Antibiot , vol.44 , pp. 136-143
    • Tomoda, H.1    Nishida, H.2    Masuma, R.3    Cao, J.4    Okuda, S.5    Omura, S.6
  • 118
    • 84892437652 scopus 로고
    • New verticillin and Glisoprenin analoues from gliocladium c atenulatum, a mycoparasite of Aspergilus flavus sclerotia
    • Tomoda, H.; Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. New verticillin and Glisoprenin analoues from gliocladium c atenulatum, a mycoparasite of Aspergilus flavus sclerotia. J. Antibiot. 1993, 45, 1202-1206.
    • (1993) J. Antibiot , vol.45 , pp. 1202-1206
    • Tomoda, H.1    Nishida, H.2    Masuma, R.3    Cao, J.4    Okuda, S.5    Omura, S.6
  • 119
    • 0026540163 scopus 로고
    • Glisoprenins, a new inhibitors of ACAT produced by Gliocladium sp. FO-1513.II. Structure elucidation o glisoprenins A & B
    • Nishida, H.; Masuma, R.; Cao, J.; Okuda, S.; Omura, S. Glisoprenins, a new inhibitors of ACAT produced by Gliocladium sp. FO-1513.II. Structure elucidation o glisoprenins A & B. J. Antibiot. 1992, 45, 1669-1676.
    • (1992) J. Antibiot , vol.45 , pp. 1669-1676
    • Nishida, H.1    Masuma, R.2    Cao, J.3    Okuda, S.4    Omura, S.5
  • 120
    • 0027259454 scopus 로고
    • GERI-BP001, a new inhibitor of ACAT produced by Aspergillus fumigates F37
    • Kiroda, K.; Yoshida, M.; Vosaic, Y. GERI-BP001, a new inhibitor of ACAT produced by Aspergillus fumigates F37. J. Antibiot. 1993, 46, 1196-1202.
    • (1993) J. Antibiot , vol.46 , pp. 1196-1202
    • Kiroda, K.1    Yoshida, M.2    Vosaic, Y.3
  • 121
    • 0028829655 scopus 로고
    • Chemical modification and SARs of pyripyropenes; potent, bioavailable inhibitor of ACAT
    • Obata, R.; Sunazuka, T.; Tomoda, H.; Harigaya, Y.; Omura, S. Chemical modification and SARs of pyripyropenes; potent, bioavailable inhibitor of ACAT. Bioorg. & Med. Chem. Lett. 1995, 5, 2683-2688.
    • (1995) Bioorg. & Med. Chem. Lett , vol.5 , pp. 2683-2688
    • Obata, R.1    Sunazuka, T.2    Tomoda, H.3    Harigaya, Y.4    Omura, S.5
  • 122
  • 124
  • 126
    • 33846568869 scopus 로고    scopus 로고
    • Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorizon
    • An, S.; Park, Y.; Paik, Y. Jeong, T.; Lee, W. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorizon. Bioorg. & Med. Chem. Lett. 2007, 17, 1112-1116.
    • (2007) Bioorg. & Med. Chem. Lett , vol.17 , pp. 1112-1116
    • An, S.1    Park, Y.2    Paik, Y.3    Jeong, T.4    Lee, W.5
  • 129
    • 0024989838 scopus 로고
    • Antiatherosclerotic agents. A structurally novel bivalent inhibitor of ACAT with systemic activity
    • Gammill, R.B.; Bell, F.P.; Bell, L.T.; Bisaha, S.N.; Wilson, G.J. Antiatherosclerotic agents. A structurally novel bivalent inhibitor of ACAT with systemic activity. J. Med. Chem. 1990, 33, 2685-2687.
    • (1990) J. Med. Chem , vol.33 , pp. 2685-2687
    • Gammill, R.B.1    Bell, F.P.2    Bell, L.T.3    Bisaha, S.N.4    Wilson, G.J.5
  • 130
    • 80053425950 scopus 로고    scopus 로고
    • Discovery of a Potent and Orally Available Acyl- CoA: Cholesterol Acyltransferase Inhibitor as an Anti atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives
    • Ogino, M.; Fukui, S.; Nakada, Y.; Tokunoh, R.; Itokawa, S.; Kakoi, Y.; Nishimura, S.; Sanada, T.; Fuse, H.; Kubo, K.; Wada, T.; Marui, S. Discovery of a Potent and Orally Available Acyl- CoA: Cholesterol Acyltransferase Inhibitor as an Anti atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives. Chem. Pharm. Bull. 2011,59, 1268-1273.
    • (2011) Chem. Pharm. Bull , vol.59 , pp. 1268-1273
    • Ogino, M.1    Fukui, S.2    Nakada, Y.3    Tokunoh, R.4    Itokawa, S.5    Kakoi, Y.6    Nishimura, S.7    Sanada, T.8    Fuse, H.9    Kubo, K.10    Wada, T.11    Marui, S.12
  • 131
    • 81455155750 scopus 로고    scopus 로고
    • Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety
    • Ogino, M.; Nakada, Y.; Negoro, N.; Itokawa, S.; Nishimura, S.; Sanada, T.; Satomi, T.; Kita, S.; Kubo, K.; Marui, S. Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety. Chem. Pharm. Bull. 2011, 59, 1369-1375.
    • (2011) Chem. Pharm. Bull , vol.59 , pp. 1369-1375
    • Ogino, M.1    Nakada, Y.2    Negoro, N.3    Itokawa, S.4    Nishimura, S.5    Sanada, T.6    Satomi, T.7    Kita, S.8    Kubo, K.9    Marui, S.10
  • 132
    • 0025734242 scopus 로고
    • Synthesis and hypocholesterolemic activity of 6,7- dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, a novel inhibitors of ACAT
    • Larsen, S.D.; Spilman, C.H.; Bell, F.P.; Dinh, D.M.; Martinborough, E.; Wilson, G.J. Synthesis and hypocholesterolemic activity of 6,7- dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, a novel inhibitors of ACAT. J. Med. Chem. 1991, 34, 1721-1727.
    • (1991) J. Med. Chem , vol.34 , pp. 1721-1727
    • Larsen, S.D.1    Spilman, C.H.2    Bell, F.P.3    Dinh, D.M.4    Martinborough, E.5    Wilson, G.J.6
  • 136
    • 77955363537 scopus 로고    scopus 로고
    • Novel Tetrahydroisoquinoline Derivatives With Inhibitory Activities Against Acyl-Coa: Cholesterol Acyltransferase And Lipid Peroxidation
    • Ohta, M.; Takahashi, K.; Kasai, M.; Shoji, Y.; Kunishiro, K.; Miike, T.; Kanda, M.; Mukai, C.; Shirahase, H. Novel Tetrahydroisoquinoline Derivatives With Inhibitory Activities Against Acyl-Coa: Cholesterol Acyltransferase And Lipid Peroxidation. Chem. Pharm. Bull. 2010, 58, 1066-1076.
    • (2010) Chem. Pharm. Bull , vol.58 , pp. 1066-1076
    • Ohta, M.1    Takahashi, K.2    Kasai, M.3    Shoji, Y.4    Kunishiro, K.5    Miike, T.6    Kanda, M.7    Mukai, C.8    Shirahase, H.9
  • 137
    • 84862149887 scopus 로고    scopus 로고
    • Discovery of novel ACAT inhibitors: Pharmacophorebased virtual screening, synthesis and pharmacology
    • Chhabria, M.T.; Brahmkshatriya, P.S.; Mahajan, B.M.; Darji, U.B.; Shah, G.B. Discovery of novel ACAT inhibitors: Pharmacophorebased virtual screening, synthesis and pharmacology. Chem. Biol. Drug. Des. 2012, 80, 106-113.
    • (2012) Chem. Biol. Drug. Des , vol.80 , pp. 106-113
    • Chhabria, M.T.1    Brahmkshatriya, P.S.2    Mahajan, B.M.3    Darji, U.B.4    Shah, G.B.5
  • 138
    • 0037877207 scopus 로고    scopus 로고
    • Inhibition of ACAT: A possible treatment of atherosclerosis
    • Heinonen, T.M. Inhibition of ACAT: A possible treatment of atherosclerosis? Curr. Atherosclerosis Reports. 2002, 4, 65-70.
    • (2002) Curr. Atherosclerosis Reports , vol.4 , pp. 65-70
    • Heinonen, T.M.1
  • 140
    • 40449110086 scopus 로고    scopus 로고
    • ACAT as a drug target for Alzheimer's disease
    • Huttunen, H.J.; Kovacs, D.M. ACAT as a drug target for Alzheimer's disease. Neurodegener Dis. 2008, 5, 212-214.
    • (2008) Neurodegener Dis , vol.5 , pp. 212-214
    • Huttunen, H.J.1    Kovacs, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.